13-Apr-2022
Coave Therapeutics to Present at Cell & Gene Meeting on the Mediterranean
Coave Therapeutics to Present at Cell & Gene Meeting on the Mediterranean
Paris, France, 13th April 2022 - Coave Therapeutics (‘Coave’), a clinical-stage biotechnology company focused on developing life-changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases, today announced that CEO Rodolphe Clerval will present a company overview at the Cell & Gene Meeting on the Mediterranean, in Barcelona, Spain at 13:45 pm CET on 20th April.
The conference, which is taking place from 20th to 22nd April 2022, is a hybrid event and the company presentation will be streamed live for virtual attendees.
A recording of the presentation will be available from the virtual platform within 24 hours for on demand viewing.
Editor Details
-
Company:
- PharmiWeb.com
-
Name:
- PW Editor
- Email:
-
Telephone:
- +441344851506
Last Updated: 13-Apr-2022
